Recent Finacing
Recent Raise
Enterome is a clinical-stage biotech developing microbiome-derived therapeutics and diagnostics, including oral FimH blocker EB8018 for Crohn’s disease and peptide-based OncoMimics immunotherapies (EO2463, EO2401).
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at ENTEROME.
